secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLENO THERAPEUTICS INC (SLNO)
CIK:        0001484565
Form:       8-K
Filed at:   2024-08-15T23:59:59+00:00
Accession:  0001193125-24-201313
Event type: leadership
Sentiment:  positive
Materiality: 0.65
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Soleno Therapeutics board changes: Chairman Mario resigns for health; Dawn Bir appointed as director
--------------------------------------------------------------------------------

- Chairman Ernest Mario resigns effective August 15, 2024 for health reasons; no disagreement with company.
- Dawn Carter Bir appointed to board effective August 15, 2024; receives 13,000 RSUs vesting over 3 years.
- Matthew Pauls named Lead Independent Director; Andrew Sinclair chairs Compensation Committee.
- Bir brings over 30 years biotech experience, led commercial launches at Reata and Pharmacyclics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484565/000119312524201313/0001193125-24-201313-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484565/000119312524201313/d856535d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-201313

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer